Nuveen Asset Management, LLC Evolus, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 897,106 shares of EOLS stock, worth $9.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

897,106

Previous 595,279 50.7%

Holding current value

$9.77 Million

Previous $6.46 Million 125.04%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.66 - $17.48 $3.22 Million - $5.28 Million	301,827 Added 50.7%	897,106 $14.5 Million
Q2 2024 Aug 09, 2024	SELL	$10.45 - $13.76 $595,503 - $784,127	-56,986 Reduced 8.74%	595,279 $6.46 Million
Q1 2024 May 13, 2024	SELL	$9.99 - $14.91 $2.7 Million - $4.04 Million	-270,639 Reduced 29.32%	652,265 $9.13 Million
Q4 2023 Feb 14, 2024	SELL	$7.6 - $10.53 $2.67 Million - $3.7 Million	-351,265 Reduced 27.57%	922,904 $9.72 Million
Q3 2023 Nov 14, 2023	BUY	$7.15 - $10.2 $4.15 Million - $5.91 Million	579,854 Added 83.51%	1,274,169 $11.6 Million
Q2 2023 Aug 14, 2023	SELL	$7.23 - $10.52 $789,103 - $1.15 Million	-109,143 Reduced 13.58%	694,315 $5.05 Million
Q1 2023 May 15, 2023	SELL	$7.81 - $11.05 $983,536 - $1.39 Million	-125,933 Reduced 13.55%	803,458 $6.8 Million
Q4 2022 Feb 14, 2023	BUY	$6.52 - $8.95 $171,150 - $234,937	26,250 Added 2.91%	929,391 $6.98 Million
Q3 2022 Nov 14, 2022	SELL	$7.76 - $13.72 $958,259 - $1.69 Million	-123,487 Reduced 12.03%	903,141 $7.27 Million
Q2 2022 Aug 15, 2022	BUY	$10.22 - $13.94 $960,894 - $1.31 Million	94,021 Added 10.08%	1,026,628 $11.9 Million
Q1 2022 May 16, 2022	BUY	$5.22 - $11.78 $81,306 - $183,485	15,576 Added 1.7%	932,607 $10.2 Million
Q4 2021 Feb 14, 2022	BUY	$5.37 - $8.38 $569,499 - $888,715	106,052 Added 13.08%	917,031 $5.15 Million
Q3 2021 Nov 12, 2021	BUY	$7.36 - $13.67 $1.54 Million - $2.87 Million	209,617 Added 34.86%	810,979 $6.67 Million
Q2 2021 Aug 16, 2021	BUY	$8.42 - $13.96 $4.43 Million - $7.35 Million	526,591 Added 704.27%	601,362 $7.61 Million
Q1 2021 May 17, 2021	SELL	$3.2 - $16.51 $30,739 - $158,595	-9,606 Reduced 11.38%	74,771 $971,000
Q4 2020 Feb 16, 2021	SELL	$2.92 - $4.84 $19,876 - $32,945	-6,807 Reduced 7.47%	84,377 $284,000
Q3 2020 Nov 16, 2020	BUY	$3.03 - $5.48 $59,224 - $107,112	19,546 Added 27.28%	91,184 $356,000
Q2 2020 Aug 14, 2020	SELL	$3.53 - $6.17 $52,402 - $91,593	-14,845 Reduced 17.17%	71,638 $379,000
Q1 2020 May 14, 2020	BUY	$3.53 - $12.21 $71,563 - $247,533	20,273 Added 30.62%	86,483 $358,000
Q4 2019 Feb 14, 2020	BUY	$11.58 - $17.37 $13,826 - $20,739	1,194 Added 1.84%	66,210 $806,000
Q3 2019 Nov 14, 2019	BUY	$13.91 - $19.87 $161,606 - $230,849	11,618 Added 21.76%	65,016 $1.02 Million
Q2 2019 Aug 15, 2019	BUY	$13.19 - $28.36 $704,319 - $1.51 Million	53,398 New	53,398 $781,000

Others Institutions Holding EOLS

# of Institutions

168

Shares Held

47.8M

Call Options Held

130K

Put Options Held

51K

View Full List

About Evolus, Inc.

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $611M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

More about EOLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Evolus, Inc. Transaction History